[Prostate cancer - enzalutamide extends survival].  [electronic resource] 

 -  Aktuelle Urologie  Mar 2014 
 - 98 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; News; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1438-8820 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Receptor Antagonists--adverse effects<br/>Benzamides<br/>Disease Progression<br/>Double-Blind Method<br/>Humans<br/>Male<br/>Nitriles<br/>Orchiectomy<br/>Phenylthiohydantoin--adverse effects<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Survival Analysis<br/>Tumor Burden